Humacyte (HUMA) Return on Sales [ROS] (2020 - 2026)
Humacyte's Return on Sales [ROS] was -6649.26% in Q2 2026, up 3226.82 percentage points from -9876.08% a year earlier but down 803.81 percentage points from the prior quarter.
Powered by 
Analysis
Humacyte (HUMA) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Humacyte's Return on Sales [ROS] was -5240.78% through Jun 30, 2026, up 8359.46 percentage points year-over-year; for FY2025, it was -5306.04%.
- Quarterly Return on Sales [ROS] has moved between -46671.78% (Q3 2024) and -3239.04% (Q3 2025) over five years.
- Compared with a year earlier, Return on Sales [ROS] was higher in two of the last four quarters, with an average year-over-year change of +11169.52 percentage points.
- Per Business Quant data, HUMA's Return on Sales [ROS] in the three quarters before Q2 2026 was -5845.45% (Q1 2026), -6603.00% (Q4 2025) and -3239.04% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 28.37% |
| 10 | Humacyte | 101.19 Mn | -97.25 Mn | -825,000.00 | -6,649.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6,649.26% |
| Mar 31, 2026 | -5,845.45% |
| Dec 31, 2025 | -6,603.00% |
| Sep 30, 2025 | -3,239.04% |
| Jun 30, 2025 | -9,876.08% |
| Mar 31, 2025 | -4,487.43% |
| Sep 30, 2024 | -46,671.78% |
| Jun 30, 2024 | -9,252.64% |
| Sep 30, 2021 | -8,524.07% |
| Sep 30, 2020 | -1,883.26% |
API Access
Humacyte Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=HUMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "HUMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=HUMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();